| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 08/22/2002 | US20020115862 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines |
| 08/22/2002 | US20020115859 Of the class 3,3,5,5-tetramethyl-2-oxo-1,4-piperazine, polymers thereof; stabilizers for thermoplastic organic polymers, coating compositions or photographic materials |
| 08/22/2002 | US20020115855 Process for the preparation of 3-aryl-benzofuran-2-ones |
| 08/22/2002 | US20020115709 Atorvastatin hemi-calcium form VII |
| 08/22/2002 | US20020115703 Administering an alpha2-adrenoceptor antagonist or a pharmaceutically acceptable ester or salt thereof, such as atipamezole, analogs of idazoxan, and analogs of efaroxan. |
| 08/22/2002 | US20020115671 Inhibitors of p38-a kinase |
| 08/22/2002 | US20020115666 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives |
| 08/22/2002 | US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance |
| 08/22/2002 | US20020115653 Retinoic acid mimetic anilides |
| 08/22/2002 | US20020115640 Such as 4-(((6-chloro-2-(3-chlorophenyl)-3-pyridinyl) methoxy)(1-methyl-1H-imidazol-5-yl)methyl)benzonitrile; anticancer agents |
| 08/22/2002 | US20020115567 Substituted 2-amino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 08/22/2002 | CA2437643A1 Matrix metalloproteinase inhibitors |
| 08/22/2002 | CA2437122A1 Quinazolines as mmp-13 inhibitors |
| 08/22/2002 | CA2434982A1 Pyridine matrix metalloproteinase inhibitors |
| 08/21/2002 | EP1232153A2 Imidazole derivatives and their use as raf kinase inhibitors |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232147A1 Triazoles as farnesyl transferase inhibitors |
| 08/21/2002 | EP1231923A1 Protease inhibitors |
| 08/21/2002 | EP1231921A1 Protease inhibitors |
| 08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 08/21/2002 | CN1365359A Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 08/21/2002 | CN1365357A Trifluoromethyl pyri(mi) diene carboxamides |
| 08/21/2002 | CN1365355A Quinoline derivatives as inhibitors of MEK enzymes |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/20/2002 | US6437138 5-bromo-6-chloro-3-(2-(s)-azetidinyl or pyrrolidinyl-methoxy) pyridine intermediates for the 5-substituted compounds which are potent ligands at neuronal nicotinic cholinergic channel receptors, neurotransmitter controlling agents |
| 08/20/2002 | US6437136 Bromide salt formation and bromination of 1-methylpiperidin-4-one, reaction with 1,3,5-trimethoxybenzene, catalytic hydrogenation to cis compound; chemical intermediate in synthesis of flavopiridol |
| 08/20/2002 | US6436989 Prodrugs of aspartyl protease inhibitors |
| 08/20/2002 | US6436981 Dihydrotriazolone derivatives as pesticides |
| 08/20/2002 | US6436964 Piperidine derivatives having effects on serotonin related systems |
| 08/20/2002 | US6436961 Substance p receptor antagonist; 2-phenyl-3-benzylaminopiperidines |
| 08/20/2002 | US6436956 Less hygroscopic antidepressant |
| 08/20/2002 | US6436943 Use of dihydropyrimidines as medicaments, and novel substances |
| 08/20/2002 | US6436940 Combined effects of dopamine d4 receptor ligands and serotonin reuptake inhibitors; schizophrenia; antidepressant; anxiolytic agents; psychological disorders; panic, sleep and obsessive compulsive disorders; antiischemic agents |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436915 Antiproliferative and antitumor agents and angiogenesis inhibitors |
| 08/15/2002 | WO2002062790A1 Preparation of n-methylparoxetine and related intermediate compounds |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062764A1 Fused heterocyclic compounds |
| 08/15/2002 | WO2002062762A2 Potassium channel openers |
| 08/15/2002 | WO2002062761A1 Aminal diones as potassium channel openers |
| 08/15/2002 | WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | WO2002062295A2 Pyridine-substituted benzanilides as potassium ion channel openers |
| 08/15/2002 | WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods |
| 08/15/2002 | WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001030768A9 Methods and compositions utilizing quinazolinones |
| 08/15/2002 | US20020111495 Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
| 08/15/2002 | US20020111494 N-type calcium channel blockers, antiischemic agents |
| 08/15/2002 | US20020111485 Optically active epoxy compound |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | US20020111358 Phenoxypropylamine compounds |
| 08/15/2002 | US20020111356 Phosphodiesterase inhibitor; antiinflammatory agents |
| 08/15/2002 | CA2437492A1 Fused heterocyclic compounds |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437392A1 Preparation of n-methylparoxetine and related intermediate compounds |
| 08/15/2002 | CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 08/15/2002 | CA2436461A1 Pyridine-substituted benzanilides as potassium ion channel openers |
| 08/14/2002 | EP1231208A2 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 08/14/2002 | EP1230235A1 Compounds with antibacterial and antiparasitic properties |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230224A1 Substituted 5-benzyl-2,4-diaminopyrimidines |
| 08/14/2002 | EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor |
| 08/14/2002 | EP1230216A1 Positive modulators of nicotinic receptor agonists |
| 08/14/2002 | EP1087961B1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 08/14/2002 | EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/14/2002 | EP0986541A4 Process for covalently coupling organic compounds utilizing diboron derivatives |
| 08/14/2002 | EP0930291B1 Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0754683B1 Ether compound, use thereof, and intermediate for producing the compound |
| 08/14/2002 | EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds |
| 08/14/2002 | CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1089086C Luminide and macroluminide class of pharmaceuticals |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433179 Process for producing paroxetine |
| 08/13/2002 | US6433178 3-alkyl-3-phenyl-piperidines |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433002 Pesticidal 1-polyarylpyrroles |
| 08/13/2002 | US6432997 Systemic insecticides, nematocides, larvicides, miticides, and anthelmintics; agriculture, horticulture |
| 08/13/2002 | US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells |
| 08/13/2002 | US6432990 Fungicides |
| 08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432952 Central nervous system disorders; antiinflammatory agents |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060878A1 Benzimidazolidinone derivatives |
| 08/08/2002 | WO2002060877A1 Imidazole derivatives |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060874A1 Potassium channel inhibitors |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |